GlucoTrack, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 7.1 million compared to USD 4.44 million a year ago. Basic loss per share from continuing operations was USD 0.38 compared to USD 0.29 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5601 USD | -0.52% | -8.18% | +114.19% |
22/04 | GlucoTrack, Inc. announced that it has received $0.5 million in funding | CI |
16/04 | Glucotrack Expanding Glucose Monitoring Technology to Epidural Space | MT |
1st Jan change | Capi. | |
---|---|---|
+114.19% | 15.06M | |
+20.65% | 47.02B | |
+49.51% | 41.86B | |
+0.22% | 41.76B | |
-4.27% | 28.8B | |
+11.71% | 26.05B | |
-21.64% | 19.15B | |
+4.33% | 12.55B | |
+28.89% | 12.34B | |
-4.43% | 11.82B |
- Stock Market
- Equities
- GCTK Stock
- News GlucoTrack, Inc.
- GlucoTrack, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023